Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | NQO2 | P16083 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 4/20 | 0.42 |
| ▸ | RAB9A | P51151 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.41 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrazine SCHEMBL27569854 | 0.96 | DYRK1A (0.50) | DYRK1AKDM4EMAPTLMNANQO2 | |
| SCHEMBL11305559 | 0.91 | DYRK1A (0.42) | DYRK1AKDM4EMAPTLMNANQO2 | |
| SCHEMBL10526428 | 0.89 | DYRK1A (0.41) | DYRK1AKDM4EMAPTLMNANQO2 | |
| SCHEMBL423908 | 0.83 | DYRK1A (0.49) | DYRK1AKDM4EMAPTNQO2NPC1 | |
| SCHEMBL29687792 | 0.83 | DYRK1A (0.49) | DYRK1AKDM4EMAPTNQO2NPC1 | |
| SCHEMBL9298986 | 0.80 | CTNNB1 (0.52) | KDM4EMAPTNPC1RAB9ASMN1; SMN2 | |
| Ethylene SCHEMBL18420722 | 0.79 | DYRK1A (0.46) | DYRK1AKDM4EMAPTNQO2NPC1 | |
| Benzene SCHEMBL152659 | 0.79 | CTNNB1 (0.51) | DYRK1AKDM4ENQO2NPC1RAB9A | |
| Benzo[D]Oxazole SCHEMBL10438872 | 0.79 | NQO2 (0.50) | DYRK1AKDM4ENQO2NPC1RAB9A | |
| SCHEMBL24425916 | 0.77 | DYRK1A (0.72) | DYRK1ALMNANPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120058630-A | Triaryl substituted vinyl compound and synthesis method thereof | 海南大学 | 2025-05-30 | — | — | CN | claimed |
| CN-117926287-A | Method for synthesizing 2-aminobenzoxazole derivative under electrochemical condition | 湘潭大学 | 2024-04-26 | — | — | CN | claimed |
| US-20190071416-A1 | COMPOUNDS FOR TREATMENT OF CANCER AND EPIGENETICS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2019-03-07 | — | — | US | claimed |
| EP-3371151-A1 | COMPOUNDS FOR TREATMENT OF CANCER AND EPIGENETICS | Agency For Science, Technology And Research (SG) | 2018-09-12 | — | — | EP | claimed |
| WO-2017061957-A1 | COMPOUNDS FOR TREATMENT OF CANCER AND EPIGENETICS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-04-13 | — | — | WO | claimed |
| EP-2091929-A1 | AGENTS THAT DISRUPT CELLULAR REPLICATION AND THEIR USE IN INHIBITING PATHOLOGICAL CONDITIONS | The European Molecular Biology Laboratory (DE) | 2009-08-26 | — | — | EP | claimed |
| CN-101421257-A | Agents that disrupt cellular replication and their use in inhibiting pathological conditions | EUROPEAN MOLECULAR BIOLOGY LAB EMBL (DE) | 2009-04-29 | — | — | CN | claimed |
| WO-2007107352-A1 | AGENTS THAT DISRUPT CELLULAR REPLICATION AND THEIR USE IN INHIBITING PATHOLOGICAL CONDITIONS | THE EUROPEAN MOLECULAR BIOLOGY LABORATORY (DE) | 2007-09-27 | — | — | WO | claimed |
| EP-0278509-B1 | Silver halide photographic emulsion | FUJI PHOTO FILM CO LTD (JP) | 1996-01-24 | — | — | EP | claimed |
| EP-0271260-B1 | Supersensitization of silver halide emulsions | MINNESOTA MINING & MFG (US) | 1995-01-04 | — | — | EP | claimed |
| US-4970141-A | ELEVATED SPECTRAL SENSITIVITY IN GREEN WAVELENGTH REGION | FUJI PHOTO FILM CO., LTD. (JP) | 1990-11-13 | — | — | US | claimed |
| US-4891305-A | LASERS | RICOH CO., LTD. (JP) | 1990-01-02 | — | — | US | claimed |
| US-4889796-A | CONTAINING BENZOXAZOLE COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1989-12-26 | — | — | US | claimed |
| US-4873184-A | ADDITION OF A METAL COMPLEXING AGENT TO THE EMULSION; HIGH SPEED | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-10-10 | — | — | US | claimed |
| US-4772534-A | PHOTORESISTS | FUJI PHOTO FILM CO., LTD. (JP) | 1988-09-20 | — | — | US | claimed |
| EP-0278509-A2 | Silver halide photographic emulsion | FUJI PHOTO FILM CO., LTD. (JP) | 1988-08-17 | — | — | EP | claimed |
| EP-0271260-A2 | Supersensitization of silver halide emulsions | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1988-06-15 | — | — | EP | claimed |
| US-4154616-A | BENZOXAZOLE OR NAPHTHOXAZOLE MEROCYANINE DYE | FUJI PHOTO FILM CO., LTD. (JP) | 1979-05-15 | — | — | US | claimed |
| US-4057430-A | MEROCYANINE THIOHYDANTOIN SENSITIZERS | FUJI PHOTO FILM CO., LTD. (JA) | 1977-11-08 | — | — | US | claimed |
| US-3970461-A | Fogged, direct-positive silver halide emulsion containing carbocyanine dye having indolenine nucleus | FUJI PHOTO FILM CO., LTD. (JA) | 1976-07-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190071416-A1 | COMPOUNDS FOR TREATMENT OF CANCER AND EPIGENETICS | SMYD3, SMYD2, EHMT1 | DYRK1A 3452/4885KDM4E 54/4885MAPT 4633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.